Genomic & Biopharma News

Low carbohydrate intake linked to increased risk of having babies with neural tube defects
Women who are pregnant or planning to become pregnant may want to avoid diets that reduce or eliminate carbohydrates, as they could increase the risk of having babies with neural tube birth defects, according to a new study from the University of North Carolina at Chapel Hill.
News Medical Life Sciences, 2018-01-25 16:25:08

Biogen's in the hunt for late-stage assets, executives say amid Q4 revenue beat
Biogen CEO Michel Vounatsos doesn’t “see a frenzy” of M&A coming to pharma because of an influx of overseas cash. But what activity he does predict? He expects to be part of it.
Fierce Pharma, 2018-01-25 16:11:36

On heels of Juno deal, Celgene reports volume-driven growth in 2017 led by stalwart Revlimid
Despite its struggles in 2017, Celgene turned in 16% sales growth for the year, buoyed by key drugs Revlimid, Pomalyst and Otezla. And some recent M&A could keep the growth coming.
Fierce Pharma, 2018-01-25 16:03:21

Herbal products may affect properties of prescription drugs and lead to dangerous side effects
An analysis of published studies and reports indicates that a number of herbal products may affect the properties of prescription drugs, leading to alterations in the drugs' effectiveness as well as potentially dangerous side effects.
News Medical Life Sciences, 2018-01-25 15:59:00

EuroBiotech Report—Ablynx-Novo, Heptares CSO departs, Allergan eyes KaNDy, Synpromics-UCL and CRISPR
In this week's EuroBiotech Report, Ablynx backer talks Novo deal, Heptares CSO leaves for Merck, Allergan eyes KaNDy and more. 
Fierce Biotech, 2018-01-25 15:57:11

Study identifies factors that impact quality of life in retirement and older age
Researchers from the University of Birmingham have found that raising your level of education and skills during your working life are key factors in determining your quality of life in retirement and older age.
News Medical Life Sciences, 2018-01-25 15:54:52

Diabetes patients more prone to serious infections, research shows
Diabetes patients have an increased risk of suffering serious infections or death compared to the general public, new research has shown.
News Medical Life Sciences, 2018-01-25 15:44:05

Summit Therapeutics unveils encouraging early data for Duchenne drug
At 24 weeks, Summit's ezutromid raised utrophin levels and reduced muscle damage in a phase 2 trial. If the trend continues, the utrophin modulator has the potential to become a wider, disease-modifying treatment for the muscle-wasting disease.
Fierce Biotech, 2018-01-25 15:40:50

EuroBiotech: More Articles of Note
In our EuroBiotech roundup this week, a phase 3 cancer flop hits PharmaMar, Ablynx hires a CSO and Genfit starts its pediatric NASH program.
Fierce Biotech, 2018-01-25 15:36:14